Long-Term Assets: The sum of all assets classified as non-current.
Cue Biopharma, Inc. (CUE) had Long-Term Assets of $5.83M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.15M |
|
$-7.45M |
|
-- |
|
$2.15M |
|
$9.74M |
|
$-7.59M |
|
$0.15M |
|
$-7.45M |
|
$-7.45M |
|
$-7.45M |
|
$-7.45M |
|
$-7.45M |
|
$-7.45M |
|
$-7.59M |
|
$-7.69M |
|
100.87M |
|
100.87M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$25.82M |
|
$0.31M |
|
|
Long-Term Assets |
$5.83M |
$31.64M |
|
$15.52M |
|
$0.19M |
|
$2.87M |
|
$18.40M |
|
$13.25M |
|
$13.25M |
|
$13.25M |
|
77.78M |
|
| Cash Flow Statement Financials | |
$-20.61M |
|
$-6.95M |
|
$16.80M |
|
$22.61M |
|
$11.85M |
|
$-10.76M |
|
$4.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
0.01 |
|
0.12 |
|
100.00% |
|
-353.42% |
|
-353.42% |
|
-- |
|
-346.58% |
|
-346.58% |
|
$-20.77M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
5.55 |
|
16.21 |
|
-56.23% |
|
-56.23% |
|
-23.54% |
|
-55.43% |
|
$0.17 |
|
$-0.21 |
|
$-0.20 |
|